Abstract
AbstractOtitis media (OM), known as a middle ear infection, is the leading cause of antibiotic prescriptions for children. With wide-spread use of antibiotics in OM, resistance to antibiotics continues to decrease the efficacy of the treatment. Furthermore, as the presence of a middle ear biofilm has contributed to this reduced susceptibility to antimicrobials, effective interventions are necessary. A miniaturized 3D-printed microplasma jet array has been developed to inactivate Pseudomonas aeruginosa, a common bacterial strain associated with OM. The experiments demonstrate the disruption of planktonic and biofilm P. aeruginosa by long-lived molecular species generated by microplasma, as well as the synergy of combining microplasma treatment with antibiotic therapy. In addition, a middle ear phantom model was developed with an excised rat eardrum to investigate the antimicrobial effects of microplasma on bacteria located behind the eardrum, as in a patient-relevant setup. These results suggest the potential for microplasma as a new treatment paradigm for OM.
Funder
McGinnis Medical Innovation Fellowship Program
National Science Foundation
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,Microbiology,Biotechnology
Reference52 articles.
1. Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95–108 (2004).
2. Selby, M. & Wolfram, S. Antibiotics for otitis media in children. Am. Fam. Physician 97, 775A–775B (2018).
3. Rovers, M. M., Schilder, A. G. M., Zielhuis, G. A. & Rosenfeld, R. M. Otitis media. Lancet 363, 465–473 (2004).
4. Lieberthal, A. S. et al. The diagnosis and management of acute otitis media. Pediatrics 131, e964–e999 (2013).
5. Schilder, A. G. M. et al. Otitis media. Nat. Rev. Dis. Prim. 2, 1–19 (2016).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献